Research ArticleBasic Science Investigations
Multimodal Imaging with 18F-FDG PET and Cerenkov Luminescence Imaging After MLN4924 Treatment in a Human Lymphoma Xenograft Model
Robbie Robertson, Melissa Saylor Germanos, Mark G. Manfredi, Peter G. Smith and Matthew D. Silva
Journal of Nuclear Medicine November 2011, 52 (11) 1764-1769; DOI: https://doi.org/10.2967/jnumed.111.091710
Robbie Robertson
Melissa Saylor Germanos
Mark G. Manfredi
Peter G. Smith
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 52, Issue 11
November 1, 2011
Multimodal Imaging with 18F-FDG PET and Cerenkov Luminescence Imaging After MLN4924 Treatment in a Human Lymphoma Xenograft Model
Robbie Robertson, Melissa Saylor Germanos, Mark G. Manfredi, Peter G. Smith, Matthew D. Silva
Journal of Nuclear Medicine Nov 2011, 52 (11) 1764-1769; DOI: 10.2967/jnumed.111.091710
Multimodal Imaging with 18F-FDG PET and Cerenkov Luminescence Imaging After MLN4924 Treatment in a Human Lymphoma Xenograft Model
Robbie Robertson, Melissa Saylor Germanos, Mark G. Manfredi, Peter G. Smith, Matthew D. Silva
Journal of Nuclear Medicine Nov 2011, 52 (11) 1764-1769; DOI: 10.2967/jnumed.111.091710
Jump to section
Related Articles
Cited By...
- Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
- Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma
- {beta}-Radioluminescence Imaging: A Comparative Evaluation with Cerenkov Luminescence Imaging
- Cerenkov-Specific Contrast Agents for Detection of pH In Vivo
- In Vivo Localization of 90Y and 177Lu Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model